__NUXT_JSONP__("/drugs/Gusperimus_Trihydrochloride", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"84937-45-1",chebiId:"",chemicalFormula:"C17H37N7O3.3HCl",definition:"A derivative of the antitumor antibiotic spergualin with immunosuppressant activity.  Gusperimus inhibits the interleukin-2-stimulated maturation of T cells to the S and G2\u002FM phases and the polarization of the T cells into IFN-gamma-secreting Th1 effector T cells, resulting in the inhibition of growth of activated naive CD4 T cells; this agent may suppress growth of certain T-cell leukemia cell lines.",fdaUniiCode:"QZS4144IO0",identifier:"C1598",preferredName:b,semanticType:"Organic Chemical",subclassOf:["C574"],synonyms:["(+-)-15-Deoxyspergualin","1-Amino-19-guanidino-11-hydroxy-4,9,12-triazanonadecane-10,13-dione","15-Deoxyspergualin","15-Deoxyspergualin Hydrochloride","7-[(Aminoiminomethyl)amino]-N-[2-[[4-[(3-aminopropyl)amino]butyl]amnio]-1-hydroxy-2-oxoethyl]heptanamide","BMS-181173","BMY-42215-1","DSG","Deoxyspergualin","Deoxyspergualin Hydrochloride","GUSPERIMUS TRIHYDROCHLORIDE",b,"N-[[[4-[(3-Aminopropyl)amino]-butyl]carbamoyl]hydroxymethyl]-7-guanidinoheptanamide","NKT-01","Spanidin"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FGusperimus_Trihydrochloride",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Gusperimus_Trihydrochloride","Gusperimus Trihydrochloride","2021-10-30T13:34:57.893Z")));